Australien - Englisch - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - tapentadol hydrochloride, quantity: 58.24 mg (equivalent: tapentadol, qty 50 mg) - tablet, modified release - excipient ingredients: titanium dioxide; lactose monohydrate; propylene glycol; hypromellose; purified talc; colloidal anhydrous silica; macrogol 6000; microcrystalline cellulose; magnesium stearate - palexia sr is indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long-term treatment. palexia sr is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. palexia sr is not indicated as an as-needed (prn) analgesia.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - tapentadol hydrochloride, quantity: 116.48 mg (equivalent: tapentadol, qty 100 mg) - tablet, film coated - excipient ingredients: croscarmellose sodium; magnesium stearate; lactose monohydrate; iron oxide yellow; purified talc; povidone; titanium dioxide; iron oxide red; polyvinyl alcohol; microcrystalline cellulose; macrogol 3350; iron oxide black - palexia ir is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - tapentadol hydrochloride, quantity: 87.36 mg (equivalent: tapentadol, qty 75 mg) - tablet, film coated - excipient ingredients: macrogol 3350; polyvinyl alcohol; iron oxide red; croscarmellose sodium; purified talc; lactose monohydrate; titanium dioxide; microcrystalline cellulose; povidone; magnesium stearate; iron oxide yellow - palexia ir is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - tapentadol hydrochloride, quantity: 58.24 mg (equivalent: tapentadol, qty 50 mg) - tablet, film coated - excipient ingredients: purified talc; titanium dioxide; croscarmellose sodium; polyvinyl alcohol; lactose monohydrate; macrogol 3350; microcrystalline cellulose; povidone; magnesium stearate - palexia ir is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

blackmores ltd - calcium pantothenate, quantity: 21.8 mg (equivalent: pantothenic acid, qty 20 mg); pyridoxine hydrochloride, quantity: 10 mg (equivalent: pyridoxine, qty 8.23 mg); ascorbic acid, quantity: 180 mg; manganese sulfate monohydrate, quantity: 6.16 mg (equivalent: manganese, qty 2 mg); biotin, quantity: 25 microgram; inositol, quantity: 25 mg; heavy magnesium oxide, quantity: 30.63 mg (equivalent: magnesium, qty 17.5 mg); zinc oxide, quantity: 6.2 mg (equivalent: zinc, qty 5 mg); folic acid, quantity: 200 microgram; calcium carbonate, quantity: 100 mg (equivalent: calcium, qty 40 mg); ferrous sulfate, quantity: 16 mg (equivalent: iron, qty 5 mg); choline bitartrate, quantity: 25 mg; d-alpha-tocopheryl acid succinate, quantity: 16.53 mg; potassium sulfate, quantity: 55.75 mg (equivalent: potassium, qty 25 mg); riboflavine, quantity: 8.5 mg; cyanocobalamin, quantity: 10 microgram; nicotinamide, quantity: 60 mg; thiamine nitrate, quantity: 7.5 mg; colecalciferol, quantity: 0.01 mg; retinol palmitate, quantity: 2.75 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; titanium dioxide; hypromellose; magnesium stearate; calcium hydrogen phosphate dihydrate; glycerol; iron oxide yellow; carnauba wax; hydrogenated vegetable oil; chlorophyllin-copper complex; sodium starch glycollate; maize starch; silicon dioxide; dl-alpha-tocopherol; sucrose; hydrolysed gelatin; hydrogenated soya oil; potable water; gelatin; butylated hydroxytoluene; aluminium starch octenylsuccinate; aluminium sodium silicate

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - ondansetron hydrochloride dihydrate, quantity: 5 mg (equivalent: ondansetron, qty 4 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; magnesium stearate; pregelatinised maize starch; sodium starch glycollate; colloidal anhydrous silica; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 400 - prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - ondansetron hydrochloride dihydrate, quantity: 10 mg (equivalent: ondansetron, qty 8 mg) - tablet, film coated - excipient ingredients: lactose monohydrate; pregelatinised maize starch; magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; sodium starch glycollate; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 400 - prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

blackmores ltd - zinc oxide, quantity: 6.2 mg (equivalent: zinc, qty 5 mg); riboflavine, quantity: 8.5 mg; nicotinamide, quantity: 60 mg; calcium pantothenate, quantity: 21.8 mg (equivalent: pantothenic acid, qty 20 mg); colecalciferol, quantity: 0.01 mg; d-alpha-tocopheryl acid succinate, quantity: 16.53 mg; ascorbic acid, quantity: 180 mg; pyridoxine hydrochloride, quantity: 10 mg; biotin, quantity: 25 microgram; cyanocobalamin, quantity: 10 microgram; folic acid, quantity: 200 microgram; choline bitartrate, quantity: 25 mg; inositol, quantity: 25 mg; retinol palmitate, quantity: 2.78 mg; calcium carbonate, quantity: 100 mg (equivalent: calcium, qty 40 mg); magnesium oxide, quantity: 30.63 mg (equivalent: magnesium, qty 17.5 mg); manganese sulfate monohydrate, quantity: 6.16 mg (equivalent: manganese, qty 2 mg); potassium sulfate, quantity: 55.75 mg (equivalent: potassium, qty 25 mg); thiamine nitrate, quantity: 7.5 mg; ferrous sulfate, quantity: 16 mg (equivalent: iron, qty 5 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; calcium hydrogen phosphate; hydrogenated vegetable oil; magnesium stearate; sodium starch glycollate; chlorophyllin-copper complex; glycerol; iron oxide yellow; titanium dioxide; carnauba wax; hypromellose; maize starch; silicon dioxide; dl-alpha-tocopherol; sucrose; hydrolysed gelatin; hydrogenated soya oil; gelatin

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

south intraco pty ltd - ferrous fumarate, quantity: 3.04 mg (equivalent: iron, qty 1 mg); riboflavine, quantity: 1.2024 mg; nicotinamide, quantity: 13.4865 mg; zinc amino acid chelate, quantity: 1 mg (equivalent: zinc, qty 100 microgram); calcium pantothenate, quantity: 8.25 mg (equivalent: pantothenic acid, qty 7.4 mg); colecalciferol, quantity: 0.01 mg; d-alpha-tocopheryl acid succinate, quantity: 1.3 mg; ascorbic acid, quantity: 60 mg; pyridoxine hydrochloride, quantity: 1.0589 mg; biotin, quantity: 50 microgram; cyanocobalamin, quantity: 4.5 microgram; folic acid, quantity: 30 microgram; retinol palmitate, quantity: 1.375 mg; calcium hydrogen phosphate, quantity: 43 mg (equivalent: calcium, qty 10 mg); calcium carbonate, quantity: 9 mg (equivalent: calcium, qty 3.6 mg); copper gluconate, quantity: 42.86 microgram (equivalent: copper, qty 6 microgram); potassium sulfate, quantity: 4.46 mg (equivalent: potassium, qty 2 mg); thiamine nitrate, quantity: 1.0589 mg; magnesium carbonate hydrate, quantity: 10 mg (equivalent: magnesium, qty 2.5 mg) - tablet, film coated - excipient ingredients: sucralose; glucose; sodium cyclamate; saccharin sodium; fructose; stearic acid; colloidal anhydrous silica; magnesium stearate; calcium hydrogen phosphate; microcrystalline cellulose; maltodextrin; hypromellose; potable water; gelatin; butylated hydroxytoluene; aluminium starch octenylsuccinate; aluminium sodium silicate; sucrose; silicon dioxide; mono- and di- glycerides; maize starch; acacia; dl-alpha-tocopherol; medium chain triglycerides; flavour - for the maintenance & improvement of general well-being in kids. helps ensure children are getting essential vitamins and minerals needed for healthy growth and development.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - hydrochlorothiazide, quantity: 25 mg; irbesartan, quantity: 300 mg - tablet, film coated - excipient ingredients: magnesium stearate; polysorbate 80; hypromellose; colloidal anhydrous silica; mannitol; sodium starch glycollate type b; povidone; titanium dioxide; iron oxide red; macrogol 3350; carnauba wax; iron oxide black - indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.